Released Nov 14, 2011, after the close
10-Q filed Nov 14, 2011, 45 days after period end · 0001437749-11-008609
Q3 2011 · 10-Q
Revenue$574.09K$574.09K +5.1% vs Q3 2010−41.7% vs Q2 2011
Net Income-$540.17K-$540.17K N/M vs Q3 2010N/M vs Q2 2011
EPS Diluted-$0.01-$0.01 no prior Q3 2010 on fileN/M vs Q2 2011
Gross Profit$363,202+6.8%
Operating Income-$533,970N/M
Operating Cash Flowderived$158,889−2.6%
Free Cash Flowderived$155,489−1.7%
Margins · derived
Gross margin63.3%+1.0 pt vs Q3 2010
Operating margin-93.0%+42.9 pt vs Q3 2010
Net margin-94.1%+78.6 pt vs Q3 2010
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $574.09K | $546.38K |
| Net Income | -$540.17K | -$943.79K |
| EPS Diluted | -$0.01 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Key International Inc · CIK 1019034 · Engraved from SEC EDGAR